James Mulshine to Leukoplakia, Oral
This is a "connection" page, showing publications James Mulshine has written about Leukoplakia, Oral.
Connection Strength
0.663
-
Not significant but important. Cancer Prev Res (Phila). 2013 May; 6(5):371-4.
Score: 0.433
-
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73.
Score: 0.230